CARMA FUND I invests in early-stage companies and projects in Life Science and Healthcare, leveraging exclusive academic access, cross-sector expertise, and a strong European syndication network. The fund focuses on risk-mitigated value creation and long-term support to bring innovative solutions to market, addressing unmet patient needs across therapeutics, diagnostics, MedTech, and digital health.
Preferred startup development maturity for initial funding deployment.
Early-stage Life Science and Healthcare technologies, including therapeutics, diagnostics, MedTech, and digital health solutions.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
